LevelJump Healthcare Corp. is pleased to announce that, subject to regulatory consent, the Company has agreed to settle $37,500 of indebtedness through the issuance of 125,000 units at a price of $0.30 per Unit to an arm’s length trade creditor . Each Unit will be comprised of one common share and one common share purchase warrant entitling the holder to purchase one additional Share of the Company until December …
LevelJump Healthcare Corp. (TSXV: JUMP) (“the “Company”) is pleased to announce that, subject to regulatory consent, the Company has agreed to settle $37,500 of indebtedness (the “Debt Conversion”) through the issuance of 125,000 units (the “Units”) at a price of $0.30 per Unit to an arm’s length trade creditor (the “Creditor”). Each Unit will be comprised of one common share (“Share”) and one common share purchase warrant (“Warrant”) entitling the holder to purchase one additional Share of the Company until December 13, 2023, at an exercise price of CA$0.45 per share.
The Company has entered into this transaction to allow it to use the retained cash for due diligence on prospective acquisitions in connection with its business plan. Additionally, as a result of this debt conversion, other than ongoing trade payables, the Company has no outstanding liabilities. The Creditor is arm’s-length to the Corporation and there are no finder’s fees payable.
The Debt Conversion will close following receipt of final acceptance of the TSXV. All securities to be issued pursuant to the offering will be subject to the applicable statutory, exchange and regulatory hold period of four months and one day and any other required resale restrictions. The securities to be issued have not and will not be registered under the US Securities Act of 1933, as amended, or any state securities laws.
About Leveljump Healthcare
LevelJump Healthcare Corp. (TSXV: JUMP) is building a national medical diagnostic imaging company and brand, primarily by providing Teleradiology (remote radiology) services to its client hospitals and imaging centers. Additionally, JUMP plans to expand through the acquisition of independent healthcare facilities focused on diagnostic imaging as well as acquiring new disruptive imaging technologies.
ON BEHALF OF THE BOARD OF DIRECTORS OF
LevelJump Healthcare Corp.
Mitchell Geisler, Chief Executive Officer
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
This news release contains “forward-looking information” within the meaning of applicable securities laws relating to the Company’s business plans and the outlook of the Company’s industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).
Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/73968
News Provided by Newsfile via QuoteMedia